Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.
暂无分享,去创建一个
H. Höfler | P. Dettmar | F. Jänicke | M. Schmitt | W. Kuhn | U. Reuning | H. Graeff | B. Schmalfeldt | L. Pache | M. Schmitt